Binder Excipients Market

Global Binder Excipients Market: Overview

• An excipient is a pharmacologically inactive substance formulated alongside the active pharmaceutical ingredient of a medication. The pharmaceutical industry always tries to satisfy patient’s therapeutical needs and apart from active ingredients, inactive excipients play a major role in formulation development. Binder excipients are formulated to act as an adhesive to literally bind together powders, granules, and other dry ingredients to provide necessary mechanical strength. In other words, binders are essential to achieve the hardness of the tablet. Binders are usually selected on the basis of product needs and vendor preference. The primary criterion when choosing a binder is its compatibility with other tablet components.
• The global binder excipients market is projected to expand at a significant pace during the forecast period, owing to rise in uses in various pharmaceutical products

Key Drivers of Global Binder Excipients Market

• Increase in demand for various pharmaceutical products on account of aging population and rising cases of chronic diseases act as the major factor driving the binder excipients market worldwide. Moreover, rise in demand for excipients with more functionality is further projected to fuel the requirement for binder excipients in drug manufacturing companies.
• Rise in number of clinical trials of new drugs is likely to drive the demand for binder excipients.

Market Restraints

• Lack of separate guidelines for manufacturing and approval of excipients is deterring R&D initiatives related to novel binder excipients. Under the present regulatory scenario, if a new drug approval fails, the excipient also fails even if it is not due to anything related to the excipient. Furthermore, clinical trial data from that failed excipient is not usable. This leads to major financial loss on the part of both the drug and the excipient manufacturer.

Asia Pacific to Hold Major Share of Global Binder Excipients Market

• Asia Pacific is likely to dominate the global binder excipients market due to increase in requirement of binder excipients in the local drug manufacturing industry for generic drugs business. Generic drug producers in countries such as India hold a strong position in the global market and play an integral role in developing the pharmaceutical industry which also created a strong demand for binder excipients for generic drugs. At present, pharmaceutical companies in India supply over 80% of the anti-retro-viral drugs used globally to combat AIDS (Acquired Immuno Deficiency Syndrome). In 2017–2018, India exported about US$ 3.2 Bn worth of generic drugs to the U.S.

Key Players Operating in Global Market

Major players operating in the global binder excipients market are:

• BASF SE
• Lonza Group
• BENEO
• DFE Pharma
• Kerry Inc.
• DuPont de Nemours, Inc.
• JRS PHARMA
• Ashland
• BPSI Holdings LLC.

Global Binders Excipients Market: Research Scope

Global Binders Excipients Market, by Source

• Natural
  • Animal
  • Microbial
  • Plant
• Synthetic

Global Binders Excipients Market, by Application

• Solution Binder
• Dry Binder

Global Binders Excipients Market, by End-user

• Pharmaceutical Companies
• Nutraceutical Companies
• Others

Global Binders Excipients Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa